Citation: Jw. Ko et al., TICLOPIDINE IS A POTENT INHIBITOR OF CYP2C19 AND CYP2D6 IN-VITRO, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 13-13
Authors:
KO JW
SUKHOVA N
THACKER D
CHEN P
FLOCKHART DA
Citation: Jw. Ko et al., EVALUATION OF OMEPRAZOLE AND LANSOPRAZOLE AS INHIBITORS OF CYTOCHROME-P450 ISOFORMS, Drug metabolism and disposition, 25(7), 1997, pp. 853-862
Authors:
SALCEDO JA
FLOCKHART DA
MAHER KA
SUKHOVA N
BENJAMIN SB
Citation: Ja. Salcedo et al., PHARMACOKINETIC PROFILE OF OMEPRAZOLE AND INTRAGASTRIC PH IN GERD PATIENTS THAT RELAPSE OX MAINTENANCE THERAPY, Gastroenterology, 112(4), 1997, pp. 277-277
Authors:
KO JW
SUKHOVA N
THACKER D
CHEN P
FLOCKHART DA
Citation: Jw. Ko et al., EVALUATION OF OMEPRAZOLE AND LANSOPRAZOLE AS INHIBITORS OF CYTOCHROME-P450 ISOFORMS, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 23-23
Authors:
BALIAN JD
SUKHOVA N
HARRIS JW
HEWETT J
PICKLE L
GOLDSTEIN JA
WOOSLEY RL
FLOCKHART DA
Citation: Jd. Balian et al., THE HYDROXYLATION OF OMEPRAZOLE CORRELATES WITH S-MEPHENYTOIN METABOLISM - A POPULATION STUDY, Clinical pharmacology and therapeutics, 57(6), 1995, pp. 662-669
Authors:
CAVUTO NJ
SUKHOVA N
HEWETT J
BALIAN JD
WOOSLEY RL
FLOCKHART DA
Citation: Nj. Cavuto et al., EFFECT OF OMEPRAZOLE ON THEOPHYLLINE CLEARANCE IN POOR METABOLIZERS OF OMEPRAZOLE, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 215-215
Authors:
BALIAN JD
SUKHOVA N
HEWETT J
HARRIS JW
WOOSLEY RL
FLOCKHART DA
Citation: Jd. Balian et al., METABOLITES OF OMEPRAZOLE AS PROBES FOR THE S-MEPHENYTOIN POLYMORPHISM, Clinical research, 42(2), 1994, pp. 10000253-10000253
Citation: Jd. Balian et al., OMEPRAZOLE - A PROBE FOR THE S-MEPHENYTOIN HYDROXYLATION, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 169-169